@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Athens_Univ-AU105410 a mbo:MassSpectrum ;
    dcterms:creator "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens" ;
    dcterms:date "2016-02-26"^^xsd:date ;
    dcterms:identifier "MSBNK-Athens_Univ-AU105410" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Copyright (C) 2016 Department of Chemistry, University of Athens under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Bruker maXis Impact" ;
            mbo:collision_energy "40 eV" ;
            mbo:column_name "ACQUITY UPLC BEH Amide 1.7 um 2.1x100mm, Waters" ;
            mbo:flow_gradient "0/100 at 0-2 min, 95/5 at 12 min, 95/5 at 17 min, 0/100 at 17.1, 0/100 at 25 min" ;
            mbo:flow_rate "200 uL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "35000" ;
            mbo:retention_time "6.331 min" ;
            mbo:solvent "A Water with 0.01% formic acid and 1mM ammonium formate",
                "B Acetonitrile:Water 95:5 with 0.01% formic acid and 1mM ammonium formate" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",
                "Erythromycin" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 7.334612e+02 ;
            rdfs:seeAlso cas:114-07-8,
                chemspider:12041,
                pubchem:CID12560 ;
            schema:inChI "InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1" ;
            schema:inChIKey inchikey:ULGZDMOVFRHVEP-RWJQBGPGSA-N ;
            schema:molecularFormula "C37H67NO13" ;
            schema:name "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",
                "Erythromycin" ;
            schema:smiles "CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O" ] ;
    mbo:has_peak [ mbo:intensity 3.948e+03 ;
            mbo:mz 1.160707e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 14 ],
        [ mbo:intensity 2.692e+03 ;
            mbo:mz 5.223461e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 1.692e+03 ;
            mbo:mz 5.403577e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 3.872e+03 ;
            mbo:mz 5.58365e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 14 ],
        [ mbo:intensity 1.632e+03 ;
            mbo:mz 5.593721e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 1.336e+04 ;
            mbo:mz 5.763767e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 47 ],
        [ mbo:intensity 5.356e+03 ;
            mbo:mz 5.773795e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 19 ],
        [ mbo:intensity 5.844e+03 ;
            mbo:mz 1.161075e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 21 ],
        [ mbo:intensity 2.204e+03 ;
            mbo:mz 1.230807e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 5.996e+03 ;
            mbo:mz 1.270754e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 21 ],
        [ mbo:intensity 2.8264e+05 ;
            mbo:mz 1.581179e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 2.302e+04 ;
            mbo:mz 1.591208e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 81 ],
        [ mbo:intensity 2.216e+03 ;
            mbo:mz 1.601216e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 4.08e+03 ;
            mbo:mz 2.331544e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 14 ],
        [ mbo:intensity 2.42e+03 ;
            mbo:mz 4.082747e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 9 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 3.012864e+02 ;
            mbo:precursor_mz 7.344685e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 15 ;
    mbo:pk_splash "splash10-0a4i-0900000000-2eb11cf954a1b785f42a" ;
    rdfs:comment "INTERNAL_ID 1054" ;
    skos:definition "Erythromycin; LC-ESI-QTOF; MS2; HILIC; CE: 40 eV; R=35000; [M+H]+" .

